MINOXIDIL (FOR MEN) Drug Patent Profile
✉ Email this page to a colleague
When do Minoxidil (for Men) patents expire, and what generic alternatives are available?
Minoxidil (for Men) is a drug marketed by P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hikma, L Perrigo Co, Sight Pharms, and Teva. and is included in eleven NDAs.
The generic ingredient in MINOXIDIL (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. Ninety-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minoxidil (for Men)
A generic version of MINOXIDIL (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Summary for MINOXIDIL (FOR MEN)
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 42 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 57 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MINOXIDIL (FOR MEN) at DailyMed |
Recent Clinical Trials for MINOXIDIL (FOR MEN)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Industrial Farmacéutica Cantabria, S.A. | Phase 3 |
Bioskin GmbH | Phase 3 |
BioClever 2005 S.L. | Phase 3 |
Pharmacology for MINOXIDIL (FOR MEN)
Drug Class | Arteriolar Vasodilator |
Physiological Effect | Arteriolar Vasodilation |